Success in Comaneci-assist Coils Embolization Surveillance Study (SUCCESS)
Public ClinicalTrials.gov record NCT04518670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Success in Comaneci-assist Coils Embolization Surveillance Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Comaneci Embolization Assist Device is indicated for use in the neurovasculature as a temporary endovascular device used to assist in the coil embolization of wide-necked intracranial aneurysms with a neck width ≤ 10 mm. A wide-necked intracranial aneurysm (IA) defines the neck width as ≥ 4 mm or a dome-to-neck ratio \< 2. The objective of the Postmarket Surveillance Plan is to assess safety and performance as used in postmarket clinical practice in the U.S.
Study identification
- NCT ID
- NCT04518670
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 24, 2020 (Actual)
- Primary completion
- May 1, 2024 (Actual)
- Completion
- Jul 7, 2024 (Actual)
- Last update posted
- Jan 21, 2026
2020 – 2024
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USA Health University Hospital | Mobile | Alabama | 36617 | — |
| Carondelet St. Joseph's Hospital (Tenet) | Tucson | Arizona | 85711 | — |
| Santa Barbara Cottage | Santa Barbara | California | 93105 | — |
| Los Robles | Thousand Oaks | California | 91360 | — |
| Baptist Health Research Institute | Jacksonville | Florida | 32207 | — |
| St. Mary's Medical Ctr (Tenet) | West Palm Beach | Florida | 33407 | — |
| University of Buffalo | Buffalo | New York | 14203 | — |
| Texas Stroke Institute (Sarah Cannon TN) | Dallas | Texas | 75075 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04518670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2026 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04518670 live on ClinicalTrials.gov.